Skip to main content

Promising Results in Trial of Artificial Pancreas System for Pregnant Women With Type 1 Diabetes

title

Mount Sinai is one of three U.S. sites participating in a clinical trial of an experimental “artificial pancreas” system customized for the stringent glucose targets recommended for optimal maternal and fetal outcomes of pregnancies complicated by diabetes.

Referring a patient is easy. Just click the “Refer a Patient Online” button.

Learn More